IDEX Analyst Price Targets - Benzinga

IDEX Corp

IEXNYSE

Trade with Public

Trade with Public

$227.98

-2.45-1.06%

Últ. Act.: Sep 30, 4:03 PM

$227.98

-2.45-1.06%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Dividendos Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

IDEX Analyst Price Targets - Benzinga

IDEX Analyst Price Targets

Wall Street analyst price targets and consensus rating for IDEX (IEX).

Price Target Range — 12 Quarters

Analyst Consensus — 10 Analysts

8Buy

2Hold

Consensus RatingBuy# Analysts10Avg. Consensus PT$260Upside to Avg. PT+13.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 9, 2026	Oppenheimer	Bryan Blair	PT Raise	Outperform	$265→$270
Aug 12, 2026	Mizuho	Brett Linzey	Upgrade	Neutral→Outperform	$210→$280
Aug 6, 2026	DA Davidson	Matt Summerville	PT Raise	Neutral	$230→$240
Aug 6, 2026	Argus Research	John Eade	PT Raise	Buy	$250→$260
Jul 30, 2026	Citigroup	Vladimir Bystricky	PT Raise	Buy	$252→$269
Jul 30, 2026	RBC Capital	Deane Dray	PT Raise	Outperform	$261→$280
Jul 30, 2026	Stifel	Nathan Jones	PT Raise	Buy	$257→$268
Jul 30, 2026	TD Cowen	Joe Giordano	PT Raise	Buy	$260→$275
Jul 21, 2026	Oppenheimer	Bryan Blair	PT Raise	Outperform	$250→$260
Jul 20, 2026	Stifel	Nathan Jones	PT Raise	Buy	$250→$257
Jul 16, 2026	RBC Capital	Deane Dray	PT Raise	Outperform	$252→$261
Jun 2, 2026	Oppenheimer	Bryan Blair	PT Raise	Outperform	$242→$250
Apr 30, 2026	Citigroup	Vladimir Bystricky	PT Raise	Buy	$243→$252
Apr 30, 2026	TD Cowen	Joseph Giordano	PT Raise	Buy	$250→$260
Apr 30, 2026	RBC Capital	Deane Dray	PT Raise	Outperform	$225→$252
Apr 14, 2026	Stifel	Nathan Jones	PT Cut	Buy	$244→$241
Mar 27, 2026	BMO Capital	Daniel DiCicco	Initiate	Market Perform	$214
Feb 6, 2026	Argus Research	John Eade	Upgrade	Hold→Buy	$240
Feb 5, 2026	DA Davidson	Matt Summerville	PT Raise	Neutral	$180→$195
Feb 5, 2026	Citigroup	Vladimir Bystricky	PT Raise	Buy	$202→$243

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Oppenheimer Maintains Outperform on IDEX, Raises Price Target to $270

Oppenheimer analyst Bryan Blair maintains IDEX (NYSE:IEX) with a Outperform and raises the price target from $265 to $270.

Benzinga Newsdesk

This Intuitive Surgical Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Top analysts upgraded IDEX and Entegris, raised price targets. Intuitive Surgical upgraded with $500 target.

Avi Kapoor

CoreWeave To Rally Around 95%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts change outlook on top names. HC Wainwright raises price target for Belite Bio, while B of A cuts Lumentum's target.

Avi Kapoor

PRO
Mizuho Upgrades IDEX to Outperform, Raises Price Target to $280

Mizuho analyst Brett Linzey upgrades IDEX (NYSE:IEX) from Neutral to Outperform and raises the price target from $210 to $280.

Benzinga Newsdesk

PRO
DA Davidson Maintains Neutral on IDEX, Raises Price Target to $240

DA Davidson analyst Matt Summerville maintains IDEX (NYSE:IEX) with a Neutral and raises the price target from $230 to $240.

Benzinga Newsdesk

PRO
Argus Research Maintains Buy on IDEX, Raises Price Target to $260

Argus Research analyst John Eade maintains IDEX (NYSE:IEX) with a Buy and raises the price target from $250 to $260.

Benzinga Newsdesk